Blog With Breast Cancer, It’s Personal Oct 14, 2013 40 years of advances have taken us from a time when disfiguring surgery was the only real treatment option to an era where we can tailor targeted therapies for individual subgroups and patients. While it may not be possible to get rid of someone’s cancer, innovative therapies are enabling doctors to manage breast cancer more effectively. Our Long War on Cancer Oct 07, 2013 As we kick off a month filled with reminders about the most common cause of cancer in women—and a Eureka series devoted to cancer—one could and should ask why it’s been so difficult to translate the findings from research into new tools and drugs in the clinic; and what the field needs to do differently to get the job done. An Old Idea is Becoming the Future of Melanoma Therapy Sep 03, 2013 To truly appreciate what immunotherapy means for the treatment of melanoma (and eventually other cancers) it is useful to take a step back and look at the rationale and history of efforts in the field. Breast Cancer Survivors Find Support on Twitter Oct 30, 2012 As Eureka wraps up its series on cancer research innovation in honor of Breast Cancer Awareness Month, we wanted to point out how the cancer patient community is using social media to unite and share resources. Improving Cancer Drugs with Animal “Avatars” Oct 22, 2012 Patient-derived tumor xenografts show promise in the early evaluation of potential cancer therapies. Magic Bullets: The Next Evolution in Targeted Cancer Therapy Oct 16, 2012 New ‘armed antibodies’ represent proverbial magic bullets–envisioned by a Nobel Laureate 100 years ago–killing tumors with greater efficacy and fewer side effects. Treatment Advances for Acute Lymphoblastic Leukemia Increase Survival Rates Oct 01, 2012 Mortality rates for this most common childhood cancer are dropping due to remarkable advances in diagnosis and treatment. Cancer Vaccines and Adjuvants Sep 24, 2012 While the development of cancer vaccines has been challenging, its future appears promising. Ipilimumab: A Groundbreaking New Treatment for Melanoma Aug 14, 2012 Like many cancer drugs, Ipilimumab had its share of ups and downs, but received approval to treat metastatic melanoma in 2011, giving hope to patients and stimulating new research in immunotherapy. Animal Models Shed Light on Cancer of the Brain Jul 30, 2012 Poorly understood pediatric cancers, such as medulloblastoma, are investigated with experimental animal models, elucidating the genes and pathways driving the disease. Displaying results 1-10 (of 14) |< < 1 - 2 > >|
With Breast Cancer, It’s Personal Oct 14, 2013 40 years of advances have taken us from a time when disfiguring surgery was the only real treatment option to an era where we can tailor targeted therapies for individual subgroups and patients. While it may not be possible to get rid of someone’s cancer, innovative therapies are enabling doctors to manage breast cancer more effectively.
Our Long War on Cancer Oct 07, 2013 As we kick off a month filled with reminders about the most common cause of cancer in women—and a Eureka series devoted to cancer—one could and should ask why it’s been so difficult to translate the findings from research into new tools and drugs in the clinic; and what the field needs to do differently to get the job done.
An Old Idea is Becoming the Future of Melanoma Therapy Sep 03, 2013 To truly appreciate what immunotherapy means for the treatment of melanoma (and eventually other cancers) it is useful to take a step back and look at the rationale and history of efforts in the field.
Breast Cancer Survivors Find Support on Twitter Oct 30, 2012 As Eureka wraps up its series on cancer research innovation in honor of Breast Cancer Awareness Month, we wanted to point out how the cancer patient community is using social media to unite and share resources.
Improving Cancer Drugs with Animal “Avatars” Oct 22, 2012 Patient-derived tumor xenografts show promise in the early evaluation of potential cancer therapies.
Magic Bullets: The Next Evolution in Targeted Cancer Therapy Oct 16, 2012 New ‘armed antibodies’ represent proverbial magic bullets–envisioned by a Nobel Laureate 100 years ago–killing tumors with greater efficacy and fewer side effects.
Treatment Advances for Acute Lymphoblastic Leukemia Increase Survival Rates Oct 01, 2012 Mortality rates for this most common childhood cancer are dropping due to remarkable advances in diagnosis and treatment.
Cancer Vaccines and Adjuvants Sep 24, 2012 While the development of cancer vaccines has been challenging, its future appears promising.
Ipilimumab: A Groundbreaking New Treatment for Melanoma Aug 14, 2012 Like many cancer drugs, Ipilimumab had its share of ups and downs, but received approval to treat metastatic melanoma in 2011, giving hope to patients and stimulating new research in immunotherapy.
Animal Models Shed Light on Cancer of the Brain Jul 30, 2012 Poorly understood pediatric cancers, such as medulloblastoma, are investigated with experimental animal models, elucidating the genes and pathways driving the disease.
